US office airs via Business Wire

Princeton, NJ & Munich, Germany / June 22, 2009 / Business Wire/ -- The Harrison Clinical Research Group GmbH, a leading full-service, scientifically and medically driven clinical research organization with offices worldwide, is pleased to announce that Dr. Michael Willett has joined the company as President and Managing Director of HCRAmerica, based in our newly expanded Princeton, New Jersey corporate office.  Dr. Willett has worked for the past 20 years in CRO and pharmaceutical companies in the USA, and brings a wealth of experience as a senior clinical research scientist, regulatory affairs and clinical development strategist, and regulatory submission consultant.

Dr. Willett has been involved in more than 400 clinical trials and numerous drug, biologic and device registrations and product approvals across all major therapeutic areas and indications.  Dr. Willett previously founded Advanced Biomedical Research, Inc. (ABR) and successfully grew the organization as a North American-based CRO and 72-bed clinical pharmacology unit.  He also previously worked at Bristol-Myers Squibb and Marion Laboratories (now part of Sanofi-Aventis).  Dr. Willett received his Bachelor of Pharmacy and Doctor of Pharmacy degrees with honors from the University of Illinois at Chicago and completed a post-PharmD residency in adult internal medicine at Truman Medical Center and the University of Missouri-Kansas City.  Dr. Willett worked as a clinical pharmacist in a hospital-based critical care environment before focusing his career on clinical research.

Dr. Francisco Harrison, founder of HCR commented,  "I am delighted to welcome Michael to our company.  We have come to know each other over the past decade and have the highest regard for each other's talents and accomplishments.  We share the same commitment to assisting our valued clients in performing scientifically rigorous clinical trials and bringing safe and effective medicines to patients. Dr. Willett added that "I am grateful for the opportunity to join HCR and am delighted to be able to work with Dr. Harrison and his high caliber team.  I am impressed with the expertise of my HCR colleagues, the global reach of the company, and the overall commitment to patient safety, good science and quality clinical research.  I also am excited to work with the highly skilled and experienced physicians and staff in the 36-bed clinical pharmacology unit in Munich."

About HCRAmerica and Harrison Clinical Research Group GmbH

HCRAmerica is the US division of Harrison Clinical Research Group GmbH, a full-service Phase I-IV global CRO with a staff of over 400 clinical research professionals and offices in 12 countries throughout the USA, Europe and Russia. HCR also has well established partners in the USA, Canada, Scandinavia, South America, South Africa, Australia, India and Japan.  HCR has a 22-year track record of service excellence in providing timely and reliable performance of clinical trials. HCR has the understanding and strategic network to offer a full range of clinical research activities throughout the USA, Europe and worldwide. Our team is proud of its quality and is ISO 9001 certified for the performance of Phase I, II, III and IV clinical trials.